{Etokimab: A Deep Analysis into the 2022981-44-6 Protein Etokimab, designated by the specific identifier 2022981-44-6, represents a novel protein currently subject to therapeutic evaluation. This biologic agent, https://www.targetmol.com/compound/etokimab